University of Leeds Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
University of Kent Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Bristol Featured PhD Programmes
"ovarian" AND "cancer"×
10 miles
    2. >
    3. >

ovarian cancer PhD Projects, Programs & Scholarships

We have 11 ovarian cancer PhD Projects, Programs & Scholarships

  • "ovarian" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 11
  Activation of targeted DNA Damage Response as a novel therapy for Ovarian Cancer
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Dr E. Sanij, Prof R. Pearson
Applications accepted all year round
High-grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer and accounts for 70% of all ovarian cancer deaths.
Details
Type/Funding
  Dynamic changes in FANC protein expression in ovarian cancer– impact on chemosensitivity and resistance
University of Edinburgh College of Medicine and Veterinary Medicine
  Research Group: Edinburgh Cancer Research Centre
  Dr S Langdon, Prof M Arends
Application Deadline: 21 April 2019
This 3-year PhD studentship funded by the Melville Trust is available to start in September 2019 at the Cancer Research UK Edinburgh Centre, which is part of the Institute of Genetics and Molecular Medicine (IGMM) at the University of Edinburgh.
Details
Type/Funding
  Therapy-induced senescence and stemness in ovarian cancer
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Prof R. Pearson, Dr K Chan
Applications accepted all year round
Cellular senescence is a stress response characterized by a robust cell cycle arrest and is a brake for malignant transformation.
Details
Type/Funding
  (MCRC Non-Clinical) Developing cellular micromotors to improve ovarian cancer management
University of Manchester Faculty of Biology, Medicine and Health
  Dr C.K Schmidt, Prof R Edmondson, Prof D Brison, Prof S Taylor
Application Deadline: 24 March 2019
Conventional cancer chemotherapies are unspecific and elicit severe side effects. Yet, they remain the backbone of current therapies, illustrating the need for new and more specific approaches.
Details
Type/Funding
  Identification and functional characterisation of BRIT1/MCPH1 synthetic lethal genes to treat breast and ovarian cancer
University of Leeds Faculty of Medicine and Health
  Dr S Bell, Prof C A Johnson
Applications accepted all year round
Women who have undergone surgery for breast and ovarian cancer often have additional chemotherapy to kill residual cancer cells and prevent recurrence.
Details
Type/Funding
  Characterize the role of Treacle (TCOF1) in AKT-regulated ribosome biogenesis
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Prof R. Pearson, Dr J Kang
Applications accepted all year round
Ribosomes are essential for cell growth and proliferation, and their biogenesis requires exquisite regulation.
Details
Type/Funding
  Inhibition of PRMT5 as a cancer therapy
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
Details
Type/Funding
  Parallels between wound healing and cancer – role of epithelial to mesenchymal transition (EMT)
University of Bradford Faculty of Life Sciences
  Research Group: Centre for Skin Sciences
  Dr M J Thornton, Prof A M Graham
Applications accepted all year round
Wound healing and cancer metastasis share common early signalling pathways that have led to the hypothesis that tumours are “wounds that do not heal”, a phrase first coined by Virchow in the 19th century.
Details
Type/Funding
  Impact of targeted therapy on the melanoma immune microenvironment
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
The treatment of melanoma is undergoing a fundamental change due to the success of both targeted therapies directed at the MAPK/ERK pathway and immunotherapies.
Details
Type/Funding
  Personalised risk evaluation in DCIS: are there molecular biomarkers that can predict which DCIS are at higher risk for recurrence?
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Dr K. Gorringe, Prof I. Campbell
Applications accepted all year round
Breast screening using mammography has seen an increased detection of not only invasive breast cancer, but also pre-invasive lesions such as ductal carcinoma in situ (DCIS).
Details
Type/Funding
Show 10 15 30 per page
4k+

PhD Project & Programmes
Search for PhDs
PhDs by Subject
PhDs by Institution
PhDs by Country
PhDs by Email
Info for students
Postgraduate Open Days
PhD Study Guides
PhD Study Abroad
Funding Your PhD
Postgraduate Advice Forum
Postgraduate Email Updates
Info for advertisers
Advertise your PhD Project & Programmes
Provider Login
Display Advertising
Targeted Emails

FindAPhD. Copyright 2005-2019
All rights reserved.